The Central Drugs Standard Control Organisation (CDSCO) has issued an important clarification regarding the definition and use of cosmetic products in India. The regulatory authority has stated that products administered through injections cannot be classified as cosmetics under existing Indian laws. The clarification comes at a time when aesthetic and beauty enhancement procedures involving injections are becoming increasingly popular across the country.
In its latest public notice, CDSCO emphasized that cosmetics are products meant to be applied externally to the human body for cleansing, beautifying, enhancing attractiveness, or altering appearance. According to the Drugs and Cosmetics Act, 1940, cosmetics include products that are rubbed, poured, sprinkled, sprayed, or otherwise applied to the external parts of the body. However, products that are injected into the body do not fall under this definition.
The clarification is expected to have a significant impact on the growing beauty and aesthetic treatment industry. Over the past few years, injectable beauty procedures have gained popularity among people seeking anti-aging treatments, facial enhancements, and other cosmetic improvements. Many clinics and service providers have often marketed such procedures under the broader category of cosmetic treatments.
CDSCO has now made it clear that the term “cosmetic” should only be used for products intended for external application. Any product administered through injections cannot legally be promoted or categorized as a cosmetic product. The move aims to prevent confusion among consumers and ensure greater transparency in the beauty and healthcare sectors.
The regulatory body also highlighted the importance of safety standards for cosmetic products. It noted that the Bureau of Indian Standards (BIS) maintains a list of ingredients that are either restricted or generally not recognized as safe (GNRAS) for use in cosmetic products. Manufacturers are required to comply with these safety guidelines while formulating and marketing their products.
Another major aspect of the notice relates to misleading advertising and labeling practices. CDSCO warned companies against making false or exaggerated claims about cosmetic products. Labels and promotional materials must accurately represent the purpose and benefits of a product without misleading consumers. Any claims that create unrealistic expectations or misrepresent the nature of a product may be considered a violation of the law.
The authority also reiterated that cosmetics cannot be marketed as treatments for medical conditions. Products sold as cosmetics should not claim to cure, prevent, or treat diseases. Such claims may place products under a different regulatory category and attract stricter oversight from health authorities.
Additionally, the notice cautioned against tampering with manufacturer labels, markings, or packaging information. Altering or removing important product details could result in legal action and regulatory penalties. Consumers are encouraged to verify product labels and report suspicious products to authorities.
Industry experts believe the clarification will help create a clearer distinction between cosmetic products and medical or aesthetic procedures. It is also expected to strengthen consumer protection by ensuring that people receive accurate information about the products and services they use.
CDSCO has urged both consumers and professionals to remain vigilant and report any violations related to prohibited ingredients, misleading claims, unauthorized treatments, or the misuse of cosmetic classifications. Regulatory authorities at both the central and state levels will continue monitoring compliance to ensure that public health and consumer interests remain protected.
The latest clarification serves as a reminder that while the beauty industry continues to evolve rapidly, safety, transparency, and regulatory compliance must remain at the forefront of all cosmetic and aesthetic practices.
